June 16, 2026 03:03 PM EDT R&DPharmaFDA+ FDA raises efficacy questions for Moderna’s flu vaccine but no dire flags Max Bayer Senior Reporter The FDA provided tepid support of Moderna’s flu vaccine ahead of an advisory meeting but, more importantly, didn’t appear to raise any major concerns that … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
83 words · extracted 1mo agoread original ↗
comments(0)
5-min edit window · permanent after that